Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation

Is 17 α ‐hydroxyprogesterone caproate contraindicated in twin gestations?

Romero, R
Conde‐agudelo, A

January 2015

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/110104/1/bjo13066.pd

17alpha-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial

Lim, A.C.
Schuit, E.
Bloemenkamp, K.
Bernardus, R.E.
Duvekot, J.J.
Erwich, J.J.
Eyck, J. van
Groenwold, R.H.
Hasaart, T.H.M.
Hummel, P.
Kars, M.M.
Kwee, A.
Oirschot, C.M. van
Pampus, M.G. van
Papatsonis, D.
Porath, M.M.
Spaanderman, M.E.A.
Willekes, C.
Wilpshaar, J.
Mol, B.W.
Bruinse, H.W.

January 2011

OBJECTIVE: To estimate whether administration of 17alpha-hydroxyprogesterone caproate can prevent ne...

17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm

Grobman, William A.
Thom, Elizabeth A.
Spong, Catherine Y.
Iams, Jay D.
Saade, George R.
Mercer, Brian M.
Tita, Alan T.N.
Rouse, Dwight J.
Sorokin, Yoram
Wapner, Ronald J.
Leveno, Kenneth J.
Blackwell, Sean
Esplin, M. Sean
Tolosa, Jorge E.
Thorp, John M.
Caritis, Steve N.
Van Dorsten, J. Peter

January 2012

To evaluate whether 17-alpha hydroxyprogesterone caproate (17-OHP) reduces preterm birth (PTB) in nu...

Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation

Caritis, Steve N.
Simhan, Hyagriv N.
Zhao, Yuan
Rouse, Dwight J.
Peaceman, Alan M.
Sciscione, Anthony
Spong, Catherine Y.
Varner, Michael W.
Malone, Fergal D.
Iams, Jay D.
Mercer, Brian M.
Thorp, John M.
Sorokin, Yoram
Carpenter, Marshall
Lo, Julie
Ramin, Susan M.
Harper, Margaret

January 2012

To evaluate in women with twin gestation the relationship between 17-hydroxyprogesterone caproate (1...

Relationship between 17-alpha hydroxyprogesterone caproate concentration and spontaneous preterm birth

Caritis, Steve N.
Venkataramanan, Raman
Thom, Elizabeth
Harper, Margaret
Klebanoff, Mark A.
Sorokin, Yoram
Thorp, John M.
Varner, Michael W.
Wapner, Ronald J.
Iams, Jay D.
Carpenter, Marshall W.
Grobman, William A.
Mercer, Brian M.
Sciscione, Anthony
Rouse, Dwight J.
Ramin, Susan

January 2014

17-alpha hydroxyprogesterone caproate (17-OHPC) 250 mg weekly reduces recurrent spontaneous preterm ...

The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies

Gyamfi, Cynthia
Horton, Amanda L.
Momirova, Valerija
Rouse, Dwight J.
Caritis, Steve N.
Peaceman, Alan M.
Sciscione, Anthony
Meis, Paul J.
Spong, Catherine Y.
Dombrowski, Mitchell
Sibai, Baha
Varner, Michael W.
Iams, Jay D.
Mercer, Brian M.
Carpenter, Marshall W.
Lo, Julie
Ramin, Susan M.
O'Sullivan, Mary Jo
Miodovnik, Menachem
Conway, Deborah

January 2009

To compare the rates of gestational diabetes (GDM) among women who received serial doses of 17 alpha...

Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation

Caritis, Steve N.
Sharma, Shringi
Venkataramanan, Raman
Rouse, Dwight J.
Peaceman, Alan M.
Sciscione, Anthony
Spong, Catherine Y.
Varner, Michael W.
Malone, Fergal D.
Iams, Jay D.
Mercer, Brian M.
Thorp, John M.
Sorokin, Yoram
Carpenter, Marshall
Lo, Julie
Ramin, Susan
Harper, Margaret

January 2011

To define the pharmacokinetic (PK) parameters of 17-hydroxyprogesterone caproate (17-OHPC) in multif...

Does 17-alpha-hydroxyprogesterone caproate affect fetal biometry and birth weight in twin pregnancy?

Mulder, E.
Versteegh, E.
Bloemenkamp, K.
Lim, A.
Mol, B.
Bekedam, D.
Kwee, A.
Bruinse, H.
Christiaens, G.

January 2013

ObjectiveIncreasingly, maternal administration of 17-α-hydroxyprogesterone caproate (17-OHPC) is uti...

Second trimester cervical length and risk of preterm birth in women with twin gestations treated with 17 alpha hydroxyprogesterone caproate

Durnwald, Celeste P.
Momirova, Valerija
Rouse, Dwight J.
Caritis, Steve N.
Peaceman, Alan M.
Sciscione, Anthony
Varner, Michael W.
Malone, Fergal D.
Mercer, Brian M.
Thorp, John M.
Sorokin, Yoram
Carpenter, Marshall W.
Lo, Julie
Ramin, Susan M.
Harper, Margaret
Spong, Catherine Y.

January 2010

To compare rates of preterm birth before 35 weeks based on cervical length measurement at 16-20 week...

Pre-Clinical and Clinical Pharmacology of 17alpha-Hydroxyprogesterone caproate (17-OHPC): An Agent for the Prevention of Preterm Birth.

Sharma, Shringi

May 2010

Preterm birth (PTB), birth prior to 37 weeks of gestational age, is a major cause of early childhood...

Salivary progesterone and estriol among pregnant women treated with 17-α-hydroxyprogesterone caproate or placebo

Klebanoff, Mark A.
Meis, Paul J.
Dombrowski, Mitchell P.
Zhao, Yuan
Moawad, Atef H.
Northen, Allison
Sibai, Baha M.
Iams, Jay D.
Varner, Michael W.
Caritis, Steve N.
O'Sullivan, Mary J.
Leveno, Kenneth J.
Miodovnik, Menachem
Conway, Deborah
Wapner, Ronald J.
Carpenter, Marshall
Mercer, Brian M.
Ramin, Susan M.
Thorp, John M.
Peaceman, Alan M.

January 2008

The objectives of the study was to determine whether salivary progesterone (P) or estriol (E3) conce...

17 alpha-Hydroxyprogesterone Caproate for the Prevention of Adverse Neonatal Outcome in Multiple Pregnancies

Lim, Arianne C.
Schuit, Ewoud
Bloemenkamp, Kitty
Bernardus, Rob E.
Duvekot, Johannes J.
Erwich, Jan Jaap H. M.
van Eyck, Jim
Groenwold, Rolf H. H.
Hasaart, Tom H. M.
Hummel, Piet
Kars, Michael M.
Kwee, Anneke
van Oirschot, Charlotte M.
van Pampus, Marielle G.
Papatsonis, Dimitri N. M.
Porath, Martina
Spaanderman, Marc E.
Willekes, Christine
Wilpshaar, Janine
Mol, Ben W. J.
Bruinse, Hein W.

September 2011

OBJECTIVE: To estimate whether administration of 17 alpha-hydroxyprogesterone caproate can prevent n...

17 alpha-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies

Lim, A.C.
Schuit, E.
Bloemenkamp, K.
Bernardus, R.E.
Duvekot, J.J.
Erwich, J.J.H.M.
van Eyck, J.
Groenwold, R.H.H.
Hasaart, T.H.M.
Hummel, P.
Kars, M.M.
Kwee, A.
van Oirschot, C.M.
van Pampus, M.G.
Papatsonis, D.
Porath, M.M.
Spaanderman, M.E.
Willekes, C.
Wilpshaar, J.
Mol, B.W.J.
Bruinse, H.W.

January 2011

OBJECTIVE: To estimate whether administration of 17 alpha-hydroxyprogesterone caproate can prevent n...

17-alpha-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: A randomized controlled trial

Lim, A.
Schuit, E.
Bloemenkamp, K.
Bernardus, R.
Duvekot, J.
Erwich, J.
van Eyck, J.
Groenwold, R.
Hasaart, T.
Hummel, P.
Kars, M.
Kwee, A.
van Oirschot, C.
van Pampus, M.
Papatsonis, D.
Porath, M.
Spaanderman, M.
Willekes, C.
Wilpshaar, J.
Mol, B.
et al.

January 2011

OBJECTIVE: To estimate whether administration of 17[alpha]-hydroxyprogesterone caproate can prevent ...

Is 17 α ‐hydroxyprogesterone caproate contraindicated in twin gestations?

Romero, R
Conde‐agudelo, A

January 2015

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/110104/1/bjo13066.pd

17alpha-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial

Lim, A.C.
Schuit, E.
Bloemenkamp, K.
Bernardus, R.E.
Duvekot, J.J.
Erwich, J.J.
Eyck, J. van
Groenwold, R.H.
Hasaart, T.H.M.
Hummel, P.
Kars, M.M.
Kwee, A.
Oirschot, C.M. van
Pampus, M.G. van
Papatsonis, D.
Porath, M.M.
Spaanderman, M.E.A.
Willekes, C.
Wilpshaar, J.
Mol, B.W.
Bruinse, H.W.

January 2011

OBJECTIVE: To estimate whether administration of 17alpha-hydroxyprogesterone caproate can prevent ne...

17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm

Grobman, William A.
Thom, Elizabeth A.
Spong, Catherine Y.
Iams, Jay D.
Saade, George R.
Mercer, Brian M.
Tita, Alan T.N.
Rouse, Dwight J.
Sorokin, Yoram
Wapner, Ronald J.
Leveno, Kenneth J.
Blackwell, Sean
Esplin, M. Sean
Tolosa, Jorge E.
Thorp, John M.
Caritis, Steve N.
Van Dorsten, J. Peter

January 2012

To evaluate whether 17-alpha hydroxyprogesterone caproate (17-OHP) reduces preterm birth (PTB) in nu...

Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation

Caritis, Steve N.
Simhan, Hyagriv N.
Zhao, Yuan
Rouse, Dwight J.
Peaceman, Alan M.
Sciscione, Anthony
Spong, Catherine Y.
Varner, Michael W.
Malone, Fergal D.
Iams, Jay D.
Mercer, Brian M.
Thorp, John M.
Sorokin, Yoram
Carpenter, Marshall
Lo, Julie
Ramin, Susan M.
Harper, Margaret

January 2012

To evaluate in women with twin gestation the relationship between 17-hydroxyprogesterone caproate (1...

Relationship between 17-alpha hydroxyprogesterone caproate concentration and spontaneous preterm birth

Caritis, Steve N.
Venkataramanan, Raman
Thom, Elizabeth
Harper, Margaret
Klebanoff, Mark A.
Sorokin, Yoram
Thorp, John M.
Varner, Michael W.
Wapner, Ronald J.
Iams, Jay D.
Carpenter, Marshall W.
Grobman, William A.
Mercer, Brian M.
Sciscione, Anthony
Rouse, Dwight J.
Ramin, Susan

January 2014

17-alpha hydroxyprogesterone caproate (17-OHPC) 250 mg weekly reduces recurrent spontaneous preterm ...

The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies

Gyamfi, Cynthia
Horton, Amanda L.
Momirova, Valerija
Rouse, Dwight J.
Caritis, Steve N.
Peaceman, Alan M.
Sciscione, Anthony
Meis, Paul J.
Spong, Catherine Y.
Dombrowski, Mitchell
Sibai, Baha
Varner, Michael W.
Iams, Jay D.
Mercer, Brian M.
Carpenter, Marshall W.
Lo, Julie
Ramin, Susan M.
O'Sullivan, Mary Jo
Miodovnik, Menachem
Conway, Deborah

January 2009

To compare the rates of gestational diabetes (GDM) among women who received serial doses of 17 alpha...

Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation

Caritis, Steve N.
Sharma, Shringi
Venkataramanan, Raman
Rouse, Dwight J.
Peaceman, Alan M.
Sciscione, Anthony
Spong, Catherine Y.
Varner, Michael W.
Malone, Fergal D.
Iams, Jay D.
Mercer, Brian M.
Thorp, John M.
Sorokin, Yoram
Carpenter, Marshall
Lo, Julie
Ramin, Susan
Harper, Margaret

January 2011

To define the pharmacokinetic (PK) parameters of 17-hydroxyprogesterone caproate (17-OHPC) in multif...

Does 17-alpha-hydroxyprogesterone caproate affect fetal biometry and birth weight in twin pregnancy?

Mulder, E.
Versteegh, E.
Bloemenkamp, K.
Lim, A.
Mol, B.
Bekedam, D.
Kwee, A.
Bruinse, H.
Christiaens, G.

January 2013

ObjectiveIncreasingly, maternal administration of 17-α-hydroxyprogesterone caproate (17-OHPC) is uti...

Second trimester cervical length and risk of preterm birth in women with twin gestations treated with 17 alpha hydroxyprogesterone caproate

Durnwald, Celeste P.
Momirova, Valerija
Rouse, Dwight J.
Caritis, Steve N.
Peaceman, Alan M.
Sciscione, Anthony
Varner, Michael W.
Malone, Fergal D.
Mercer, Brian M.
Thorp, John M.
Sorokin, Yoram
Carpenter, Marshall W.
Lo, Julie
Ramin, Susan M.
Harper, Margaret
Spong, Catherine Y.

January 2010

To compare rates of preterm birth before 35 weeks based on cervical length measurement at 16-20 week...

Pre-Clinical and Clinical Pharmacology of 17alpha-Hydroxyprogesterone caproate (17-OHPC): An Agent for the Prevention of Preterm Birth.

Sharma, Shringi

May 2010

Preterm birth (PTB), birth prior to 37 weeks of gestational age, is a major cause of early childhood...

Salivary progesterone and estriol among pregnant women treated with 17-α-hydroxyprogesterone caproate or placebo

Klebanoff, Mark A.
Meis, Paul J.
Dombrowski, Mitchell P.
Zhao, Yuan
Moawad, Atef H.
Northen, Allison
Sibai, Baha M.
Iams, Jay D.
Varner, Michael W.
Caritis, Steve N.
O'Sullivan, Mary J.
Leveno, Kenneth J.
Miodovnik, Menachem
Conway, Deborah
Wapner, Ronald J.
Carpenter, Marshall
Mercer, Brian M.
Ramin, Susan M.
Thorp, John M.
Peaceman, Alan M.

January 2008

The objectives of the study was to determine whether salivary progesterone (P) or estriol (E3) conce...

17 alpha-Hydroxyprogesterone Caproate for the Prevention of Adverse Neonatal Outcome in Multiple Pregnancies

Lim, Arianne C.
Schuit, Ewoud
Bloemenkamp, Kitty
Bernardus, Rob E.
Duvekot, Johannes J.
Erwich, Jan Jaap H. M.
van Eyck, Jim
Groenwold, Rolf H. H.
Hasaart, Tom H. M.
Hummel, Piet
Kars, Michael M.
Kwee, Anneke
van Oirschot, Charlotte M.
van Pampus, Marielle G.
Papatsonis, Dimitri N. M.
Porath, Martina
Spaanderman, Marc E.
Willekes, Christine
Wilpshaar, Janine
Mol, Ben W. J.
Bruinse, Hein W.

September 2011

OBJECTIVE: To estimate whether administration of 17 alpha-hydroxyprogesterone caproate can prevent n...

17 alpha-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies

Lim, A.C.
Schuit, E.
Bloemenkamp, K.
Bernardus, R.E.
Duvekot, J.J.
Erwich, J.J.H.M.
van Eyck, J.
Groenwold, R.H.H.
Hasaart, T.H.M.
Hummel, P.
Kars, M.M.
Kwee, A.
van Oirschot, C.M.
van Pampus, M.G.
Papatsonis, D.
Porath, M.M.
Spaanderman, M.E.
Willekes, C.
Wilpshaar, J.
Mol, B.W.J.
Bruinse, H.W.

January 2011

OBJECTIVE: To estimate whether administration of 17 alpha-hydroxyprogesterone caproate can prevent n...

17-alpha-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: A randomized controlled trial

Lim, A.
Schuit, E.
Bloemenkamp, K.
Bernardus, R.
Duvekot, J.
Erwich, J.
van Eyck, J.
Groenwold, R.
Hasaart, T.
Hummel, P.
Kars, M.
Kwee, A.
van Oirschot, C.
van Pampus, M.
Papatsonis, D.
Porath, M.
Spaanderman, M.
Willekes, C.
Wilpshaar, J.
Mol, B.
et al.

January 2011

OBJECTIVE: To estimate whether administration of 17[alpha]-hydroxyprogesterone caproate can prevent ...

Is 17 α ‐hydroxyprogesterone caproate contraindicated in twin gestations?

Romero, R
Conde‐agudelo, A

January 2015

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/110104/1/bjo13066.pd

17alpha-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial

Lim, A.C.
Schuit, E.
Bloemenkamp, K.
Bernardus, R.E.
Duvekot, J.J.
Erwich, J.J.
Eyck, J. van
Groenwold, R.H.
Hasaart, T.H.M.
Hummel, P.
Kars, M.M.
Kwee, A.
Oirschot, C.M. van
Pampus, M.G. van
Papatsonis, D.
Porath, M.M.
Spaanderman, M.E.A.
Willekes, C.
Wilpshaar, J.
Mol, B.W.
Bruinse, H.W.

January 2011

OBJECTIVE: To estimate whether administration of 17alpha-hydroxyprogesterone caproate can prevent ne...

17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm

Grobman, William A.
Thom, Elizabeth A.
Spong, Catherine Y.
Iams, Jay D.
Saade, George R.
Mercer, Brian M.
Tita, Alan T.N.
Rouse, Dwight J.
Sorokin, Yoram
Wapner, Ronald J.
Leveno, Kenneth J.
Blackwell, Sean
Esplin, M. Sean
Tolosa, Jorge E.
Thorp, John M.
Caritis, Steve N.
Van Dorsten, J. Peter

January 2012

To evaluate whether 17-alpha hydroxyprogesterone caproate (17-OHP) reduces preterm birth (PTB) in nu...

Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation

Abstract

Extracted data

Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation

Abstract

Extracted data

Related items

Related items